Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2855
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Improvac - EU/2/09/095/003 Zoetis Belgium S.A., Beļģija QG03XA91 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Gonadorelin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pfizer Animal Health s.a., Beļģija
Date of authorisation/renewal: 10-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/09/095/003 4 Polietilēna pudele, 250 ml -
LETIFEND - EU/2/16/195/002 Laboratorios LETI, S.L. unipersonal, Spānija QI07A dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Recombinant Protein Q from Leishmania infantum MON-1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 20-Apr-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/16/195/002 4 Stikla flakons, 1 deva -
Cortavance 0.584 mg/ml EU/2/06/069/003 Virbac S.A., Francija QD07AC16 dogs Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, solution
International name (active substance): Hydrocortisone aceponate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 13-Sep-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/06/069/003 0,584 mg/ml 1 ABPE pudele, 31 ml -
Synulox RTU - V/I/22/0013 Zoetis Belgium S.A., Beļģija QJ01CR02 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 31-Mar-2022
Marketing authorisation valid until: 30-Mar-2027
Marketing authorisation procedure: I
Package leaflet: [DOCX] 22062023_LI (22-Jun-2023)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/22/0013-01 1 Flakons, 100 ml [PDF] [PDF]
V/I/22/0013-02 6 Flakons, 100 ml -
Ingelvac CircoFLEX - EU/2/07/079/003 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AA07 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated recombinant Porcine Circovirus type 2
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 13-Feb-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/07/079/003 1 ABPE pudele, 100 deva -
Poulvac Procerta HVT-IBD-ND - EU/2/24/324/002 Zoetis Belgium S.A., Beļģija QI01AD16 chickens; embryonated chicken eggs Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Turkey herpesvirus, strain HVT-IBD-ND (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and fusion protein gene of Newcastle disease virus, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 23-Jan-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/324/002 1 Stikla ampula, 4000 deva -
Nobilis Rhino CV - V/I/21/0010 Intervet Ireland Ltd, Īrija QI01AD01 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension
International name (active substance): Live attenuated avian rhinotracheitis virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 01-Dec-2025
Marketing authorisation valid until: 30-Nov-2030
Marketing authorisation procedure: I
Package leaflet: [DOCX] 01122025_LI (01-Dec-2025)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/21/0010-01 1 10 Stikla flakons, 5000 deva [PDF]
V/I/21/0010-02 1 1 Stikla flakons, 1000 deva [PDF]
V/I/21/0010-03 1 10 Stikla flakons, 1000 deva [PDF]
Rhiniseng - EU/2/10/109/005 Laboratorios Hipra S.A., Spānija QI09AB04 sows; gilt Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Pasteurella multocida Serotype D,Inactivated Bordetella bronchiseptica
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 15-Sep-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/10/109/005 1 Pudele, 20 ml -
Metacam 5 mg/ml EU/2/97/004/011 Boehringer Ingelheim Vetmedica GmbH, Vācija QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 06-Dec-2007
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/97/004/011 5 mg/ml 1 Stikla flakons, 20 ml -
Ceperolon 80 mg EU/2/24/321/012 CP-Pharma Handelsgesellschaft GmbH, Vācija QC03DA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: Chewable tablet
International name (active substance): Spironolactone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 12-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/321/012 80 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
NexGard Combo - EU/2/20/267/006 Boehringer Ingelheim Vetmedica GmbH, Vācija QP54AA54 cats 2.5-7.5 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Esafoxolaner, Eprinomectin, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Animal Health France SCS., Francija
Date of authorisation/renewal: 06-Jan-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/20/267/006 3 Aplikators, 0,9 ml -
Emdocam 20 mg/ml EU/2/11/128/003 Emdoka bvba, Beļģija QM01AC06 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 21-Jun-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/11/128/003 20 mg/ml 1 Stikla pudelīte, 250 ml -
VeroBlue-3 - EU/2/26/362/001 VEROVACCiNES GmbH, Vācija QI04AA02 sheep Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Bluetongue virus, serotype 3, VP2 protein (recombinant)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 23-Apr-2026
Marketing authorisation valid until: 22-Apr-2027
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/26/362/001 1 Stikla flakons, 5 deva;Stikla flakons (šķīdinātājs), 5 ml -
Purevax RCP FeLV - EU/2/04/048/001 Boehringer Ingelheim Vetmedica GmbH, Vācija QI06AJ03 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Recombinant Canarypox virus,Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal: 23-Feb-2005
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/04/048/001 1 devas/flakonā 10 Stikla pudelīte, 1 deva -
Emevet - EU/2/25/343/003 CP-Pharma Handelsgesellschaft GmbH, Vācija QA04AD90 dogs

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 02-Jun-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/25/343/003 5 Blisteris, 10 tablete -
Nobivac LeuFel - EU/2/17/217/001 VIRBAC, Francija QI06AA01 cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated feline leukaemia virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 17-Oct-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/17/217/001 10 Stikla flakons, 1 ml -
ERYSENG PARVO - EU/2/14/167/001 Laboratorios Hipra S.A., Spānija QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Erysipelothrix rhusiopathiae ,Inactivated swine parvovirus strain
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 05-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/14/167/001 1 Stikla flakons, 10 deva -
Prevomax - EU/2/17/211/003 Dechra Regulatory B.V., Nīderlande QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Eurovet Animal Health B.V., Nīderlande;Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 11-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/17/211/003 1 Stikla flakons, 25 ml -
ReproCyc ParvoFLEX - EU/2/19/237/002 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AA02 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine Parvovirus strain 27a VP2 subunit antigen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 26-Apr-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/237/002 1 ABPE pudele, 100 ml/50 deva -
Rheumocam 5.0 mg/ml EU/2/07/078/017 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 18-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/07/078/017 5 mg/ml 1 Stikla flakons, 100 ml -

3082 records